Drupal.behaviors.print = function(context) {window.print();window.close();}>
Verinata Secures $46.5M for Development, Commercialization of Fetal Trisomy Test
August 09, 2011
Verinata Secures $46.5M for Development, Commercialization of Fetal Trisomy Test
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Sequenom Outlicenses Technology for T21 Test, Returns Rights of Separate Patent to TrovaGene
August 17, 2011 / Clinical Sequencing News
Sequenom Ramps up Hiring, Licenses Additional Technology as it Nears Launch of T21 Test
August 9, 2011 / Clinical Sequencing News
Verinata Health Sues Sequenom Over Prenatal Diagnostic Patent Rights
February 29, 2012 / Clinical Sequencing News
Verinata Health Sets March Launch Date for Trisomy Test; Presents Results from Validation Study
February 15, 2012 / Clinical Sequencing News
Verinata Licenses Quake Patent, Setting Stage for IP Tussle with Sequenom
September 7, 2011 / Clinical Sequencing News